Monocyte-mediated tumoricidal activity via the tumor necrosis factor- related cytokine, TRAIL
- Publication Type:
- Journal Article
- Citation:
- Journal of Experimental Medicine, 1999, 189 (8), pp. 1343 - 1353
- Issue Date:
- 1999-04-19
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
 | 2011003804OK.pdf | 165.7 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
TRAIL (tumor necrosis factor [TNF]-related apoptosis-inducing ligand) is a molecule that displays potent antitumor activity against selected targets. The results presented here demonstrate that human monocytes rapidly express TRAIL, but not Fas ligand or TNF, after activation with interferon (IFN)-γ or -α and acquire the ability to kill tumor cells. Monocyte-mediated tumor cell apoptosis was TRAIL specific, as it could be inhibited with soluble TRAIL receptor. Moreover, IFN stimulation caused a concomitant loss of TRAIL receptor 2 expression, which coincides with monocyte acquisition of resistance to TRAIL-mediated apoptosis. These results define a novel mechanism of monocyte-induced cell cytotoxicity that requires TRAIL, and suggest that TRAIL is a key effector molecule in antitumor activity in vivo.
Please use this identifier to cite or link to this item: